Thursday, August 1, 2019 NIH-Funded Study Suggests Targeting Cell May Help Prevent Anaphylaxis in Humans Allergies can be life-threatening particularly when they cause anaphylaxis, an extreme reaction with constriction of the airways and a sudden drop in blood pressure. Scientists have identified a subtype of immune cell that drives the production of antibodies associated with anaphylaxis and other allergic reactions. The research, published online today in the journal Science, reveals a potential target for new therapies to prevent severe allergic reactions. |
No comments:
Post a Comment